• Waldencast won FDA clearance for Obagi saypha ChIQ, an injectable hyaluronic acid gel for cheek augmentation in adults 21+.
• The decision expands Obagi Medical’s U.S. dermal filler lineup, following the launch of saypha MagIQ.
• Product was developed by Croma-Pharma.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Waldencast plc published the original content used to generate this news brief on June 15, 2026, and is solely responsible for the information contained therein.